Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Stone

Showing results (11-20 of 420) with videos related to

Pageof 42
Sort By:
Haematologica|April 1, 2021
BETing on rational combination therapy in mutant <i>FLT3</i> acute myeloid leukemiaRichard M Stone
Best Practice & Research. Clinical Haematology|November 21, 2017
Which new agents will be incorporated into frontline therapy in acute myeloid leukemia?Richard M Stone
Best Practice & Research. Clinical Haematology|November 24, 2018
What FLT3 inhibitor holds the greatest promise?Richard M Stone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2006
Is intravenous arsenic trioxide a useful therapy in myelodysplastic syndromes?Richard M Stone
Best Practice & Research. Clinical Haematology|November 23, 2015
Should older adults with AML receive post-remission therapy?Richard M Stone
Blood|August 24, 2017
Thrombosis in AML? Yes, but when to worry?Richard M Stone
Blood|April 9, 2026
Das not enough in CBF AMLRichard M Stone
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Transplantation after Remission in Mixed Phenotype Acute Leukemia: A Good IdeaRichard M Stone
The Oncologist|June 1, 2004
Optimizing treatment of chronic myeloid leukemia: a rational approachRichard M Stone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Acute myeloid leukemia in first remission: to choose transplantation or not?Richard M Stone
Pageof 42

Showing results (11-20 of 420) with videos related to

Sort By:
Pageof 42
Haematologica|April 1, 2021
BETing on rational combination therapy in mutant <i>FLT3</i> acute myeloid leukemiaRichard M Stone
Best Practice & Research. Clinical Haematology|November 21, 2017
Which new agents will be incorporated into frontline therapy in acute myeloid leukemia?Richard M Stone
Best Practice & Research. Clinical Haematology|November 24, 2018
What FLT3 inhibitor holds the greatest promise?Richard M Stone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2006
Is intravenous arsenic trioxide a useful therapy in myelodysplastic syndromes?Richard M Stone
Best Practice & Research. Clinical Haematology|November 23, 2015
Should older adults with AML receive post-remission therapy?Richard M Stone
Blood|August 24, 2017
Thrombosis in AML? Yes, but when to worry?Richard M Stone
Blood|April 9, 2026
Das not enough in CBF AMLRichard M Stone
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Transplantation after Remission in Mixed Phenotype Acute Leukemia: A Good IdeaRichard M Stone
The Oncologist|June 1, 2004
Optimizing treatment of chronic myeloid leukemia: a rational approachRichard M Stone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Acute myeloid leukemia in first remission: to choose transplantation or not?Richard M Stone
Pageof 42